About Us

Milton Wyman, D.V.M., M.S., D.A.V.C.O. Senior Ophthalmologist 2003-2021 Read More

Developing Quality Medications for Eye Care

Therapeutic Vision, Inc. is a small research company located in Omaha, Nebraska that is focused on the development of pharmaceuticals for both the human and companion animal markets. We are developing age-related and diabetic therapies for the preservation of vision and the prevention of neurodegeneration. As experts in cataract development, we offer contract toxicological research services to evaluate the effects of drugs on lens opacity and cataract formation.

Mission Statement

Our mission is to develop unique and innovative drugs that greatly benefit both humans and their companion pets.

Executive Team and Consultants

PETER F. KADOR, PH.D., F.A.R.V.O., F.A.O.P.T., F.A.A.P.S.

President and CEO

PETER F. KADOR, PH.D., F.A.R.V.O., F.A.O.P.T., F.A.A.P.S.

President and CEO

Peter Kador is the founder and president/CEO. After 25 years at the National Eye Institute, National Institutes of Health (N.I.H.) he retired as Chief of the Laboratory of Ocular Therapeutics. He was then recruited as Professor and Chair (now Professor Emeritus) of Pharmaceutical Sciences and Professor of Ophthalmology at the University of Nebraska Medical Center. He is an internationally recognized vision scientist and cataract expert.

MANLEY A. PAULOS, PH.D.

Regulatory Affairs and Clinical Director

MANLEY A. PAULOS, PH.D.

Regulatory Affairs and Clinical Director

Manley A. Paulos serves as Regulatory Affairs and Clinical Director. He has over 30 years of pharmaceutical industry experience, including positions as Medical Director (Merrell-Dow); Director, Clinical and Regulator Affairs (Bayer); President, Premier Research (CRO); and Komodo Pharmaceutical Services (drug delivery systems manufacturing).

ROBERT MUNGER, D.V.M., D.A.C.V.O.

Senior Veterinary Ophthalmologist

ROBERT MUNGER, D.V.M., D.A.C.V.O.

Senior Veterinary Ophthalmologist

Bob Munger is the Senior Veterinary Ophthalmologist, Founder of Animal Ophthalmology Clinic, Ltd., Dallas, TX, Ophthalmic Toxicology Consultant, and past President of the American College of Veterinary Ophthalmologists.

WILLIAM E. THOMPSON, B.A., C.P.A.

Treasurer and Financial Advisor

WILLIAM E. THOMPSON, B.A., C.P.A.

Treasurer and Financial Advisor

William E. Thompson is the treasurer and financial advisor. He was the managing partner of Thompson, Cooling & Associated LLC. And specializes in small business consulting, accounting, and income tax. He served as a consultant with Deloitte & Touche in their small business consulting group on IPO’s general ledger conversions and third-party reviews.

Jon Ambrose

Jon Ambrose B.S., M.B.A.

Fractional COO

JON AMBROSE B.S., M.B.A.

Fractional COO

Jon Ambrose is the Fractional COO. As CEO of Ambrose Advisory he provides fractional leadership and project execution services for high growth startups. He is a successful startup founder and M&A leader with success building companies through acquisition and raising venture financing.

SUELLEN KADOR, B.A.

Administrator

SUELLEN KADOR, B.A.

Administrator

Suellen Kador is the corporation administrator. She has 31 years of experience as a high school chemistry teacher and 6 years as a laboratory instructor at the University of Nebraska at Omaha Chemistry Department.

KAREN BLESSING, B.S., R.V.T.

Research Coordinator

KAREN BLESSING, B.S., R.V.T.

Research Coordinator

Karen Blessing is the research coordinator. Ms. Blessing has assisted Dr. Kador on his research projects at both the National Eye Institute and at the University of Nebraska Medical Center and coordinates the Kinostat® trial studies.

RICHARD J. SALVI, PH.D.

Collaborator and Advisor

RICHARD J. SALVI, PH.D.

Collaborator and Advisor

Richard J. Salvi the SUNY Emeritus Distinguished Professor of Communicative Disorders and Sciences, was the co-founder and director of the University at Buffalo’s Center for Hearing and Deafness, one of the country’s foremost hearing research groups. Currently, he is a research professor at the University of Central Florida and a collaborator of Dr. Kador.

L. DAVID WATERBURY, PH.D.

Advisor and Senior Scientist

L. DAVID WATERBURY, PH.D.

Advisor and Senior Scientist

L. David Waterbury is an expert in the treatment of inflammatory diseases, free radicals, and ocular pharmacology who is accomplished in bridging the gap between bench-top and the clinic. As Director of Raven Biosolutions LLC, he has proven success in drug development as demonstrated by publications, U.S. patents issued, and the role of selecting drugs for clinical trials.

PETER OATES, PH.D.

Scientific Consultant

PETER OATES, PH.D.

Scientific Consultant

Peter Oates is a retired Research Fellow of Diabetes Translational Pharmacology at Pfizer Global R&D at Groton, C.T., with extensive experience in diabetic complications. He is currently Chief Scientific Officer at Oates Biomedical Consulting LLC. He is also a longtime collaborator of Dr. Kad.

MARJORIE LOU, PH.D., F.A.R.V.O.

Scientific Consultant

MARJORIE LOU, PH.D., F.A.R.V.O.

Scientific Consultant

Marjorie Lou is the retired Willa Cather Professor of Biomedical Sciences at the University of Nebraska-Lincoln. Prior to this position. Dr. Lou was a research director at Alcon Laboratories, Fort Worth, TX. She is a long-time collaborator of Dr. Kador and an expert on the role of oxidation in cataract formation.

VINCE BELLAVIA, B.SCI., M.B.A.

Business Consultant

VINCE BELLAVIA, B.SCI., M.B.A

Business Consultant

Vince Bellavia serves as the business consultant. Mr. Bellavia is President and CEO of AVENTIX Animal Health Corp., a Canadian-owned and operated veterinary product marketing and distribution company.

Contact Us

Our team of specialists would be pleased to be of service to you. Learn more about what we can do for you by reaching out to us.

Connect With Us